au.\*:("LUSCHER, Thomas F")
Results 1 to 25 of 339
Selection :
ACE Inhibition and Vascular Protection in HypertensionLüSCHER, Thomas F.Journal of cardiovascular pharmacology. Supplement. 1999, Vol 34, Num 1, 38 p.Conference Proceedings
Modulation of endothelial function in cardiovascular disease: a potential role for nifedipineLüSCHER, Thomas F.Drugs (Basel). 1997, Vol 53, issn 0012-6667, 49 p., SUP1Serial Issue
Haemodynamics of the vessel wallLüSCHER, Thomas F; KUTRYK, M.Seminars in interventional cardiology. 1998, Vol 3, Num 1, issn 1084-2764, 51 p.Serial Issue
Endothelial function : General considerationsHALLER, H.Drugs (Basel). 1997, Vol 53, pp 1-10, issn 0012-6667, SUP1Article
Inflammation in Coronary Artery Disease and Acute Myocardial Infarction - is the Stage Set for Novel Therapies? : Treatment of Atherosclerosis as an Inflammatory DiseaseKLINGENBERG, Roland; LÜSCHER, Thomas F.Current pharmaceutical design (Print). 2012, Vol 18, Num 28, pp 4358-4369, issn 1381-6128, 12 p.Article
Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugsLÜSCHER, Thomas F; BARTON, Matthias.Circulation (New York, N.Y.). 2000, Vol 102, Num 19, pp 2434-2440, issn 0009-7322Article
Moving from impact to influence: measurement and the changing role of medical journalsNALLAMOTHU, Brahmajee K; LUSCHER, Thomas F.European heart journal. 2012, Vol 33, Num 23, pp 2892-2896, issn 0195-668X, 5 p.Article
Endothelial nitric oxide synthase : Host defense enzyme of the endothelium?RABELINK, Ton J; LUSCHER, Thomas F.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 2, pp 267-271, issn 1079-5642, 5 p.Article
Unexplored territories with calcium channel blockers: potential for the futureSEVER, Peter S; OPARIL, Suzanne; LüSCHER, Thomas F et al.Journal of cardiovascular pharmacology. Supplement. 1999, Vol 33, Num 2, 26 p.Conference Proceedings
Efficacy and safety of spirapril in mild-to-moderate hypertensionHAYDUK, K; KRAUL, H.Journal of cardiovascular pharmacology. Supplement. 1999, Vol 34, Num 1, pp S19-S23Conference Paper
Matching the Risk: CAD Therapy on TimeWILLICH, Stefan N; LüSCHER, Thomas F.Journal of cardiovascular pharmacology. Supplement. 1999, Vol 34, Num 2, 36 p.Conference Proceedings
From endothelial dysfunction to cardiovascular diseaseLüSCHER, Thomas F.Journal of cardiovascular pharmacology. Supplement. 1998, Vol 32, Num 3, 82 p.Conference Proceedings
Role of nitrates for the therapy of coronary artery disease patients in the years beyond 2000DARIUS, H.Journal of cardiovascular pharmacology. Supplement. 1999, Vol 34, Num 2, pp S15-S20Conference Paper
Tissue factor in cardiovascular diseases : Molecular mechanisms and clinical implicationsSTEFFEL, Jan; LÜSCHER, Thomas F; TANNER, Felix C et al.Circulation (New York, N.Y.). 2006, Vol 113, Num 5, pp 722-731, issn 0009-7322, 10 p.Article
Multiple postpartal coronary artery dissections and fibromuscular renal artery dysplasiaSCHULER, Pia K; LÜSCHER, Thomas F; KUCHER, Nils et al.European heart journal. 2008, Vol 29, Num 22, pp 2825-2825, issn 0195-668X, 1 p.Article
Pharmacological mechanisms of clinically favorable properties of a selective β1-Adrenoceptor antagonist, nebivololKUROEDOV, Alexey; COSENTINO, Francesco; LÜSCHER, Thomas F et al.Cardiovascular drug reviews (Print). 2004, Vol 22, Num 3, pp 155-168, issn 0897-5957, 14 p.Article
ETA receptors mediate vasoconstriction of large conduit arteries during reduced flow in humansSPIEKER, Lukas E; LÜSCHER, Thomas F; NOLL, Georg et al.Journal of cardiovascular pharmacology. 2003, Vol 42, Num 3, pp 315-318, issn 0160-2446, 4 p.Article
Circadian variation in cardiovascular events and implications for therapy?MULCAHY, D.Journal of cardiovascular pharmacology. Supplement. 1999, Vol 34, Num 2, pp S3-S8Conference Paper
Positron emission tomography to assess the haemodynamics of the coronary circulationCAMICI, P. G.Seminars in interventional cardiology. 1998, Vol 3, Num 1, pp 31-38, issn 1084-2764Article
Clinical experience with spirapril in human hypertensionSCHMIDT, J; KRAUL, H.Journal of cardiovascular pharmacology. Supplement. 1999, Vol 34, Num 1, pp S25-S30Conference Paper
Coronary endothelial function in health and diseaseBURNETT, J. C.Drugs (Basel). 1997, Vol 53, pp 20-29, issn 0012-6667, SUP1Article
Dizziness and Pre-Syncope: An Unusual Clinical Presentation of a Spontaneous Coronary Artery Dissection as Revealed by Optical Coherence TomographyHASUN, Matthias; MANKA, Robert; LUSCHER, Thomas F et al.Journal of the American College of Cardiology. 2011, Vol 58, Num 11, issn 0735-1097, p. 1191Article
Endothelin in atherosclerosis : Importance of risk factors and therapeutic implicationsD'USCIO, Livius V; BARTON, Matthias; SHAW, Sidney et al.Journal of cardiovascular pharmacology. Supplement. 2000, Vol 35, Num 2, pp S55-S59Conference Paper
Current strategies and perspectives for correcting endothelial dysfunction in atherosclerosisSPIEKER, Lukas E; LÜSCHER, Thomas F; NOLL, Georg et al.Journal of cardiovascular pharmacology. Supplement. 2001, Vol 38, Num 2, pp S35-S41Conference Paper
Endothelin and cardiac arrhythmias : do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs?DURU, Firat; BARTON, Matthias; LÜSCHER, Thomas F et al.Cardiovascular research. 2001, Vol 49, Num 2, pp 272-280, issn 0008-6363Article